OmniAb

OABI · NASDAQ

$4.96+$0.27 (+5.76%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $4.69

Latest news

Press releaseOct 14, 4:05 PM ETBusiness Wire
OmniAb to Report Third Quarter 2026 Financial Results on October 30
Press releaseOct 6, 8:00 AM ETBusiness Wire
OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
Press releaseSep 14, 8:00 AM ETBusiness Wire
OmniAb to Host Investor & Analyst Day on October 6, 2026
NewsSep 2, 10:26 AM ETAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Press releaseAug 26, 8:00 AM ETBusiness Wire
OmniAb to Participate in Upcoming Investor Conferences
NewsAug 17, 12:03 PM ETAvi Kapoor
Gold Gains 1%; US Home-Builder Sentiment Edges Higher In August
NewsAug 17, 9:51 AM ETAvi Kapoor
H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday
NewsAug 17, 9:15 AM ETAkanksha Bakshi
Why Is Omniab Stock Rallying After Eli Lilly Deal?
NewsAug 17, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsAug 17, 7:22 AM ET
Market-Moving News for August 17th
Press releaseAug 17, 6:06 AM ETBusiness Wire
OmniAb Raises 2026 Financial Guidance
Press releaseAug 17, 6:01 AM ETBusiness Wire
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
NewsAug 7, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseAug 6, 4:05 PM ETBusiness Wire
OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
Press releaseJul 16, 8:00 AM ETBusiness Wire
OmniAb to Report Second Quarter 2026 Financial Results on August 6
Press releaseJul 13, 8:00 AM ETBusiness Wire
OmniAb Names Amechi Nwachuku Chief Operating Officer
NewsMay 20, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseMay 7, 4:05 PM ETBusiness Wire
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
Press releaseApr 24, 8:00 AM ETBusiness Wire
OmniAb to Participate in Three Upcoming Investor Conferences
Press releaseApr 21, 8:00 AM ETBusiness Wire
OmniAb to Report First Quarter 2026 Financial Results on May 7
NewsMar 4, 4:08 PM ET
OmniAb Q4 Earnings Assessment
Press releaseMar 4, 4:05 PM ETBusiness Wire
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
NewsMar 4, 6:11 AM ET
Earnings Scheduled For March 4, 2026
NewsMar 3, 2:02 PM ET
A Look Ahead: OmniAb's Earnings Forecast
Press releaseFeb 24, 8:00 AM ETBusiness Wire
OmniAb to Participate at the Leerink Partners Global Healthcare Conference
Press releaseFeb 19, 8:00 AM ETBusiness Wire
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
Press releaseDec 15, 4:05 PM ETBusiness Wire
Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
Press releaseDec 11, 10:17 AM ETPRNewswire
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Press releaseDec 4, 4:05 PM ETBusiness Wire
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
Press releaseNov 17, 5:23 PM ETBusiness Wire
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
Press releaseNov 4, 4:05 PM ETBusiness Wire
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
NewsNov 4, 6:12 AM ET
Earnings Scheduled For November 4, 2025
Press releaseOct 16, 8:00 AM ETBusiness Wire
OmniAb to Participate in Three Investor Conferences in November
Press releaseOct 14, 8:00 AM ETBusiness Wire
OmniAb to Report Third Quarter 2025 Financial Results on November 4
Press releaseSep 2, 8:00 AM ETBusiness Wire
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
Press releaseAug 25, 7:00 AM ETBusiness Wire
OmniAb Announces $30 Million Private Placement
Press releaseAug 6, 4:05 PM ETBusiness Wire
OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

OmniAb to Report Third Quarter 2026 Financial Results on October 30

OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day

OmniAb to Host Investor & Analyst Day on October 6, 2026

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

OmniAb to Participate in Upcoming Investor Conferences

Gold Gains 1%; US Home-Builder Sentiment Edges Higher In August

H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday

Why Is Omniab Stock Rallying After Eli Lilly Deal?

12 Health Care Stocks Moving In Monday's Pre-Market Session

Market-Moving News for August 17th

OmniAb Raises 2026 Financial Guidance

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

12 Health Care Stocks Moving In Friday's Intraday Session

OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

OmniAb to Report Second Quarter 2026 Financial Results on August 6

OmniAb Names Amechi Nwachuku Chief Operating Officer

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

OmniAb Reports First Quarter 2026 Financial Results and Business Highlights

OmniAb to Participate in Three Upcoming Investor Conferences

OmniAb to Report First Quarter 2026 Financial Results on May 7

OmniAb Q4 Earnings Assessment

OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Earnings Scheduled For March 4, 2026

A Look Ahead: OmniAb's Earnings Forecast

OmniAb to Participate at the Leerink Partners Global Healthcare Conference

OmniAb to Report Fourth Quarter 2025 Financial Results on March 4

Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

Platform Technologies Drive $211B Surge in Precision Cancer Treatment

OmniAb to Hold OmniUltra Virtual Investor Event on December 15

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Earnings Scheduled For November 4, 2025

OmniAb to Participate in Three Investor Conferences in November

OmniAb to Report Third Quarter 2025 Financial Results on November 4

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

OmniAb Announces $30 Million Private Placement

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights